Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 35 Neoplasms 23 Motor Activity 11 Stomach Neoplasms 7 Pain, Postoperative 7 Lung Neoplasms 7 Fatigue 7 Colorectal Neoplasms 7 Pain 5 Anxiety Disorders 5 Polycystic Ovary Syndrome 4 Depression 4 Carcinoma, Hepatocellular 4 Uterine Cervical Neoplasms 3 Thyroid Neoplasms 3 Stomatitis 3 Sleep Initiation and Maintenance Disorders 3 Rectal Neoplasms 3 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Malnutrition 3 Liver Neoplasms 3 Leukemia, Myeloid, Acute 3 Colonic Neoplasms 3 Agnosia 3 Vomiting 2 Urinary Incontinence 2 Squamous Cell Carcinoma of Head and Neck 2 Parasomnias 2 Ovarian Neoplasms 2

Interventions

Insulin Glargine 4 Insulin 3 volagidemab 2 Metformin 2 Alpelisib 2 ziprasidone 1 olaparib 1 exemestane 1 Vildagliptin 1 Tamoxifen 1 Standard of Care 1 Olanzapine 1 Letrozole 1 Insulin Lispro 1 Insulin Aspart 1 Injections 1 Fulvestrant 1 DNA, Ribosomal 1 Control Groups 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperglycemia × Control Groups × Clear all

NCT02372539 2021-04-26

Glucose Variability in Cancer Patients Receiving Dexamethasone

University of Colorado, Denver

Hyperglycemia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡